These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 30385042

  • 1. CXCL12 blockade preferentially regenerates lost podocytes in cortical nephrons by targeting an intrinsic podocyte-progenitor feedback mechanism.
    Romoli S, Angelotti ML, Antonelli G, Kumar Vr S, Mulay SR, Desai J, Anguiano Gomez L, Thomasova D, Eulberg D, Klussmann S, Melica ME, Conte C, Lombardi D, Lasagni L, Anders HJ, Romagnani P.
    Kidney Int; 2018 Dec; 94(6):1111-1126. PubMed ID: 30385042
    [Abstract] [Full Text] [Related]

  • 2. Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders.
    Lasagni L, Ballerini L, Angelotti ML, Parente E, Sagrinati C, Mazzinghi B, Peired A, Ronconi E, Becherucci F, Bani D, Gacci M, Carini M, Lazzeri E, Romagnani P.
    Stem Cells; 2010 Sep; 28(9):1674-85. PubMed ID: 20680961
    [Abstract] [Full Text] [Related]

  • 3. Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease.
    Darisipudi MN, Kulkarni OP, Sayyed SG, Ryu M, Migliorini A, Sagrinati C, Parente E, Vater A, Eulberg D, Klussmann S, Romagnani P, Anders HJ.
    Am J Pathol; 2011 Jul; 179(1):116-24. PubMed ID: 21703397
    [Abstract] [Full Text] [Related]

  • 4. Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS.
    Zhang J, Pippin JW, Krofft RD, Naito S, Liu ZH, Shankland SJ.
    Am J Physiol Renal Physiol; 2013 Jun 01; 304(11):F1375-89. PubMed ID: 23486009
    [Abstract] [Full Text] [Related]

  • 5. Postnatal podocyte gain: Is the jury still out?
    Puelles VG, Moeller MJ.
    Semin Cell Dev Biol; 2019 Jul 01; 91():147-152. PubMed ID: 31178004
    [Abstract] [Full Text] [Related]

  • 6. Biphasic MIF and SDF1 expression during podocyte injury promote CD44-mediated glomerular parietal cell migration in focal segmental glomerulosclerosis.
    Ito N, Sakamoto K, Hikichi C, Matsusaka T, Nagata M.
    Am J Physiol Renal Physiol; 2020 Mar 01; 318(3):F741-F753. PubMed ID: 32068458
    [Abstract] [Full Text] [Related]

  • 7. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
    Dai R, Liu H, Han X, Liu J, Zhai Y, Rao J, Shen Q, Xu H.
    BMC Nephrol; 2019 May 24; 20(1):185. PubMed ID: 31126248
    [Abstract] [Full Text] [Related]

  • 8. The antiviral cytokines IFN-α and IFN-β modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration.
    Migliorini A, Angelotti ML, Mulay SR, Kulkarni OO, Demleitner J, Dietrich A, Sagrinati C, Ballerini L, Peired A, Shankland SJ, Liapis H, Romagnani P, Anders HJ.
    Am J Pathol; 2013 Aug 24; 183(2):431-40. PubMed ID: 23747509
    [Abstract] [Full Text] [Related]

  • 9. Podocyte loss involves MDM2-driven mitotic catastrophe.
    Mulay SR, Thomasova D, Ryu M, Kulkarni OP, Migliorini A, Bruns H, Gröbmayr R, Lazzeri E, Lasagni L, Liapis H, Romagnani P, Anders HJ.
    J Pathol; 2013 Jul 24; 230(3):322-35. PubMed ID: 23749457
    [Abstract] [Full Text] [Related]

  • 10. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
    Qiao Y, Wang P, Chang M, Chen B, Ge Y, Malhotra DK, Dworkin LD, Gong R.
    Clin Sci (Lond); 2020 Apr 17; 134(7):695-710. PubMed ID: 32167144
    [Abstract] [Full Text] [Related]

  • 11. Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy.
    Zoja C, Garcia PB, Rota C, Conti S, Gagliardini E, Corna D, Zanchi C, Bigini P, Benigni A, Remuzzi G, Morigi M.
    Am J Physiol Renal Physiol; 2012 Nov 01; 303(9):F1370-81. PubMed ID: 22952284
    [Abstract] [Full Text] [Related]

  • 12. Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis.
    Eng DG, Sunseri MW, Kaverina NV, Roeder SS, Pippin JW, Shankland SJ.
    Kidney Int; 2015 Nov 01; 88(5):999-1012. PubMed ID: 25993321
    [Abstract] [Full Text] [Related]

  • 13. Role of C/EBP-α in Adriamycin-induced podocyte injury.
    Zhong F, Wang W, Lee K, He JC, Chen N.
    Sci Rep; 2016 Sep 20; 6():33520. PubMed ID: 27644413
    [Abstract] [Full Text] [Related]

  • 14. Proteinuria impairs podocyte regeneration by sequestering retinoic acid.
    Peired A, Angelotti ML, Ronconi E, la Marca G, Mazzinghi B, Sisti A, Lombardi D, Giocaliere E, Della Bona M, Villanelli F, Parente E, Ballerini L, Sagrinati C, Wanner N, Huber TB, Liapis H, Lazzeri E, Lasagni L, Romagnani P.
    J Am Soc Nephrol; 2013 Nov 20; 24(11):1756-68. PubMed ID: 23949798
    [Abstract] [Full Text] [Related]

  • 15. Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes.
    Sayyed SG, Hägele H, Kulkarni OP, Endlich K, Segerer S, Eulberg D, Klussmann S, Anders HJ.
    Diabetologia; 2009 Nov 20; 52(11):2445-54. PubMed ID: 19707743
    [Abstract] [Full Text] [Related]

  • 16. Cells of renin lineage are progenitors of podocytes and parietal epithelial cells in experimental glomerular disease.
    Pippin JW, Sparks MA, Glenn ST, Buitrago S, Coffman TM, Duffield JS, Gross KW, Shankland SJ.
    Am J Pathol; 2013 Aug 20; 183(2):542-57. PubMed ID: 23769837
    [Abstract] [Full Text] [Related]

  • 17. A multicolor podocyte reporter highlights heterogeneous podocyte changes in focal segmental glomerulosclerosis.
    Tao J, Polumbo C, Reidy K, Sweetwyne M, Susztak K.
    Kidney Int; 2014 Apr 20; 85(4):972-80. PubMed ID: 24284512
    [Abstract] [Full Text] [Related]

  • 18. [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms].
    Ronconi E, Mazzinghi B, Sagrinati C, Angelotti ML, Ballerini L, Parente E, Romagnani P, Lazzeri E, Lasagni L.
    G Ital Nefrol; 2009 Apr 20; 26(6):660-9. PubMed ID: 19918748
    [Abstract] [Full Text] [Related]

  • 19. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M, Mukoyama M, Mori K, Suganami T, Sawai K, Yoshioka T, Nagae T, Yokoi H, Kawachi H, Shimizu F, Sugawara A, Nakao K.
    J Am Soc Nephrol; 2005 Sep 20; 16(9):2690-701. PubMed ID: 15987752
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy.
    Okamoto T, Sasaki S, Yamazaki T, Sato Y, Ito H, Ariga T.
    Nephron Exp Nephrol; 2013 Sep 20; 124(3-4):11-8. PubMed ID: 24401840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.